Against the background of an increasingly aging global population, the incidence of thrombotic and hemostatic diseases, including cardiovascular diseases, remains high.
Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.
The Hurun Research Institute released the 2020 Hurun Global 500 recently, a list of the 500 most valuable non-state-controlled companies in the world.
The Hurun Research Institute released the 2020 Hurun Global 500 recently, a list of the 500 most valuable non-state-controlled companies in the world.
Do I need to be vaccinated against COVID-19?
Due to January 18, a number of companies in the biomedical sector have issued performance forecasts.
Find out what is going on in Chinese in vitro diagnostic industry
Sansure Biotech released an announcement of performance increase on January 18, and it is expected that the net profit attributable to the owners of the parent company will be realized from 2.556 billion yuan to 2.8626 billion yuan in 2020.
Recently,Thermo Fisher Scientific announced that it plans to acquire Mesa Biotech,INC with USD 450 million in cash and a milestone payment of USD 100 million.
HOB Biotech Group (HOB) and Shanghai Liferiver Biotech Co., Ltd. were successfully listed on Shanghai Stock Exchange in January 2021.
HOB Biotech Group (HOB) and Shanghai Liferiver Biotech Co., Ltd. were successfully listed on Shanghai Stock Exchange in January 2021.
January 18, 2021, Pfizer China and Cepheid China formally signed a strategic cooperation agreement in Shanghai.
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.